AXA (EPA:CS) has been given a €27.00 ($31.40) price objective by research analysts at Goldman Sachs Group in a note issued to investors on Friday. The firm presently has a “buy” rating on the stock. Goldman Sachs Group’s price target indicates a potential upside of 18.42% from the company’s current price.
Other analysts have also issued research reports about the company. Baader Bank set a €28.00 ($32.56) price objective on AXA and gave the stock a “buy” rating in a report on Thursday, August 2nd. Jefferies Financial Group set a €25.00 ($29.07) price objective on AXA and gave the stock a “buy” rating in a report on Thursday, August 2nd. Kepler Capital Markets set a €28.70 ($33.37) price objective on AXA and gave the stock a “buy” rating in a report on Friday, August 3rd. Societe Generale set a €30.00 ($34.88) price objective on AXA and gave the stock a “buy” rating in a report on Friday, August 3rd. Finally, Deutsche Bank set a €27.00 ($31.40) price objective on AXA and gave the stock a “buy” rating in a report on Tuesday, October 2nd. Three equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of €26.93 ($31.31).
CS traded up €0.23 ($0.27) during midday trading on Friday, reaching €22.80 ($26.51). The company’s stock had a trading volume of 14,250,000 shares, compared to its average volume of 9,520,000. AXA has a twelve month low of €22.13 ($25.73) and a twelve month high of €27.69 ($32.20).
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates through six segments: France, Europe, Asia, the United States, International, and Transversal and Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.
See Also: What are Closed-End Mutual Funds?
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.